Llwytho...
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
BACKGROUND: Targeted therapy with tyrosine kinase inhibitors has been shown to reduce tumor volumes and prolong the survival of patients with metastatic renal cell carcinoma. Tyrosine kinase inhibitors, particularly sunitinib, have recently been used in neoadjuvant and presurgical settings. Axitinib...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | BMC Res Notes |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2013
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4222084/ https://ncbi.nlm.nih.gov/pubmed/24267160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-0500-6-484 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|